Can Less Be More? Organ Preservation Strategies in the Management of Rectal Cancer
Authors:
Open Access
- 1 November 2019
- journal article
- review article
- Published by MDPI AG in Current Oncology
- Vol. 26 (11) , 16-23
Abstract
Background: Total mesorectal excision (tme) is the current standard of care for the treatment of rectal cancer. However, that surgery is associated with significant morbidity and mortality. Clinicians and patients are seeking alternatives to radical resection. Currently, prevalent organ-sparing strategies under investigation include local excision and nonoperative management (nom). Methods: We reviewed the current evidence in the literature to create an overview of the use of transanal endoscopic surgery and watch-and-wait strategies in the modern management of rectal cancer. Results: Compared with radical resection, transanal endoscopic surgery in patients with early rectal cancer (cT1) having favourable histopathologic features is associated with an increased risk of local recurrence, but no difference in 5-year survival. In patients with T2 or early T3 cancer, strategies that use neoadjuvant or adjuvant therapy as adjuncts to local excision are under evaluation. Nonoperative management is a new option for patients who experience a complete clinical response after neoadjuvant chemoradiotherapy (ncrt). The selection criteria that will appropriately identify patients for whom nom will succeed are not established. Conclusions: Local excision is appropriate for early rectal cancer with favourable histopathologic features. Although organ-preserving strategies are promising, the quality of the evidence to date is insufficient to replace the current standard care in most patients. Patients should be offered nom in the safe setting of a clinical trial or registry. Rigorous follow-up, including endoscopy and imaging at frequent intervals is recommended when radical resection is forgone.Keywords
This publication has 48 references indexed in Scilit:
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY ExperienceJournal of Clinical Oncology, 2011
- Transanal Endoscopic Microsurgery for Residual Rectal Cancer After Neoadjuvant Chemoradiation Therapy Is Associated With Significant Immediate Pain and Hospital Readmission RatesDiseases of the Colon & Rectum, 2011
- Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinomaLaboratory Investigation, 2010
- Transanal endoscopic microsurgery is superior to transanal excision of rectal adenomasColorectal Disease, 2010
- Local Excision of Distal Rectal Cancer: An Update of Cancer and Leukemia Group B 8984Diseases of the Colon & Rectum, 2008
- Transanal Endoscopic Microsurgery is more Effective than Traditional Transanal Excision for Resection of Rectal MassesDiseases of the Colon & Rectum, 2008
- T1 Adenocarcinoma of the RectumAnnals of Surgery, 2005
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Management of early invasive colorectal cancerDiseases of the Colon & Rectum, 1995
- The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?British Journal of Surgery, 1982